These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2232849)

  • 1. A study of multidrug resistance and cell kinetics in a child with near-haploid acute lymphoblastic leukemia.
    Redner A; Hegewisch S; Haimi J; Steinherz P; Jhanwar S; Andreeff M
    Leuk Res; 1990; 14(9):771-7. PubMed ID: 2232849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
    Pieters R; Hongo T; Loonen AH; Huismans DR; Broxterman HJ; Hählen K; Veerman AJ
    Br J Cancer; 1992 May; 65(5):691-7. PubMed ID: 1350207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
    Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
    Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia.
    Kumagai M; Manabe A; Coustan-Smith E; Blakley RL; Beck WT; Santana VM; Behm FG; Raimondi SC; Campana D
    Leukemia; 1994 Jul; 8(7):1116-23. PubMed ID: 7913512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: results of a long-term prospective study.
    Dhooge C; De Moerloose B; Laureys G; Ferster A; De Bacquer D; Philippe J; Leroy J; Benoit Y
    Leuk Lymphoma; 2002 Feb; 43(2):309-14. PubMed ID: 11999562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
    Candoni A; Michelutti A; Simeone E; Damiani D; Baccarani M; Fanin R
    Eur J Haematol; 2006 Oct; 77(4):293-9. PubMed ID: 16856922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N
    Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.
    Feig SA; Ames MM; Sather HN; Steinherz L; Reid JM; Trigg M; Pendergrass TW; Warkentin P; Gerber M; Leonard M; Bleyer WA; Harris RE
    Med Pediatr Oncol; 1996 Dec; 27(6):505-14. PubMed ID: 8888809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of bcr-abl-positive acute lymphoblastic leukemia to daunorubicin is not mediated by mdr1 gene expression.
    Gupta M; Kumar A; Dabadghao S
    Am J Hematol; 2002 Nov; 71(3):172-6. PubMed ID: 12410571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult acute lymphoblastic leukemia with near haploidy, hyperdiploidy and Ph positive lines: a rare entity with poor prognosis.
    Sunil SK; Prakash PN; Hariharan S; Vinod G; Preethi RT; Geetha N; Ankathil R
    Leuk Lymphoma; 2006 Mar; 47(3):561-3. PubMed ID: 16396782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric evidence for minimal residual disease and cytological heterogeneities in acute lymphoblastic leukemia with severe hypodiploidy.
    Tsurusawa M; Kaneko Y; Katano N; Niwa M; Ito M; Fujimoto T
    Am J Hematol; 1989 Sep; 32(1):42-9. PubMed ID: 2757002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multidrug resistant gene MDR1 contributes to development of imatinib-resistance in Ph (+) acute lymphoblastic leukemia cell line SUP-BS15RI].
    Lin J; Xing HY; Gong YP; Yang X; Guo Y; Shan QQ; Zhou RQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):657-60, 665. PubMed ID: 23230732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein (P-170) expression in acute leukemias.
    Abd El-Ghaffar HA; Aladle DA; Farahat SE; Abd El-Hady N
    Hematology; 2006 Feb; 11(1):35-41. PubMed ID: 16522547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near haploid acute lymphoblastic leukemia: seven new cases and a review of the literature.
    Gibbons B; MacCallum P; Watts E; Rohatiner AZ; Webb D; Katz FE; Secker-Walker LM; Temperley IJ; Harrison CJ; Campbell RH
    Leukemia; 1991 Sep; 5(9):738-43. PubMed ID: 1943226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein mediated multidrug resistance assessment by flow-cytometry in malignant hemopathies.
    Tatu CA; Paunescu V; Stanescu DI; Schneider F
    Anticancer Res; 1997; 17(4A):2583-6. PubMed ID: 9252684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-haploid acute lymphoblastic leukemia: a unique subgroup with a poor prognosis?
    Brodeur GM; Williams DL; Look AT; Bowman WP; Kalwinsky DK
    Blood; 1981 Jul; 58(1):14-9. PubMed ID: 6940627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.
    Haddad G; Thorner PS; Bradley G; Dalton WS; Ling V; Chan HS
    Lab Invest; 1994 Oct; 71(4):595-603. PubMed ID: 7967514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission.
    Musto P; Melillo L; Lombardi G; Matera R; di Giorgio G; Carotenuto M
    Br J Haematol; 1991 Jan; 77(1):50-3. PubMed ID: 1671821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.